(Q34376205)

1 August 2017

1 reference

title

D3 dopamine receptor, behavioral sensitization, and psychosis (English)

1 reference

1 August 2017

0 references

1 reference

Richtand NM

1

1 reference

1 August 2017

Woods SC

series ordinal

2

1 reference

1 August 2017

Berger SP

series ordinal

3

1 reference

1 August 2017

Strakowski SM

series ordinal

4

1 reference

1 August 2017

1 July 2001

1 reference

Neuroscience & Biobehavioral Reviews

1 August 2017

1 reference

1 August 2017

25

1 reference

1 August 2017

5

1 reference

1 August 2017

427-443

1 reference

Long-term administration of d-amphetamine: progressive augmentation of motor activity and stereotypy

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

The experimental reproduction of amphetamine psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Multiple daily amphetamine administration: behavioral and neurochemical alterations

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Dextroamphetamine. Evaluation of psychomimetic properties in man

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Factors that predict individual vulnerability to amphetamine self-administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

The neural basis of drug craving: an incentive-sensitization theory of addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Transduction of psychosocial stress into the neurobiology of recurrent affective disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Criteria for rationally evaluating animal models of posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Effects of lesions of prefrontal cortex, amygdala, or fornix on behavioral sensitization to amphetamine: comparison with N-methyl-D-aspartate antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Two dissociable components of behavioral sensitization following repeated amphetamine administration

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Evolving behavior in the clinical and experimental amphetamine (model) psychosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

The role of the nucleus accumbens in sensitization to drugs of abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Effects of repeated amphetamine treatment on the locomotor activity of the dopamine D1A-deficient mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Behavioral responses to cocaine and amphetamine administration in mice lacking the dopamine D1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Environmental and pharmacological sensitization: effects of repeated administration of systemic or intra-nucleus accumbens cocaine.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Infusion of a D-1 receptor agonist into the nucleus accumbens enhances cocaine-induced behavioural sensitization.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Alterations in amphetamine-induced locomotor activity and stereotypy after electrical stimulation of the nucleus accumbens and neostriatum

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Behavioral sensitization is accompanied by an enhancement in amphetamine-stimulated dopamine release from striatal tissue in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Subchronic methamphetamine treatment enhances methamphetamine- or cocaine-induced dopamine efflux in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Time course of the development of the enhanced behavioral and biochemical responses to amphetamine after pretreatment with amphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

In vivo microdialysis reveals a diminished amphetamine-induced DA response corresponding to behavioral sensitization produced by repeated amphetamine pretreatment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Reduction of dopamine release and synthesis by repeated amphetamine treatment: role in behavioral sensitization.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Blockade of behavioral sensitization to cocaine and amphetamine by inhibitors of protein synthesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Application of a protein synthesis inhibitor into the ventral tegmental area, but not the nucleus accumbens, prevents behavioral sensitization to cocaine.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Dopamine receptors: from structure to function

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Cloning and expression of a rat D2 dopamine receptor cDNA

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

The putative dopamine D3 receptor agonist 7-OH-DPAT: lack of mesolimbic selectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Regional quantification of D1, D2, and D3 dopamine receptor mRNA in rat brain using a ribonuclease protection assay

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Differential visualization of dopamine D2 and D3 receptor sites in rat brain. A comparative study using in situ hybridization histochemistry and ligand binding autoradiography.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Differential distribution of D3 dopamine receptors in the brains of several mammalian species.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Dopamine D3 receptors expressed by all mesencephalic dopamine neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

The third dopamine receptor (D3) as a novel target for antipsychotics

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Functional implications of multiple dopamine receptor subtypes: the D1/D3 receptor coexistence

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Coexpression of dopamine D1 and D3 receptors in islands of Calleja and shell of nucleus accumbens of the rat: opposite and synergistic functional interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Opposing roles for dopamine D2 and D3 receptors on neurotensin mRNA expression in nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Combined use of mutant mice and classical pharmacology to characterise receptor functions: the case of dopamine D2 and D3 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Central administration of dopamine D3 receptor antisense to rat: effects on locomotion, dopamine release and [3H]spiperone binding

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

D3 receptor knockdown through antisense oligonucleotide administration supports its inhibitory role in locomotion

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Opposite effects of dopamine D2 and D3 receptors on learning and memory in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Behavioural effects of the putative D-3 dopamine receptor agonist 7-OH-DPAT in relation to other "D-2-like" agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Behavioral and biochemical effects of the dopamine D3 receptor-selective ligand, 7-OH-DPAT, in the normal and the reserpine-treated rat

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Locomotor inhibition by the D3 ligand R-(+)-7-OH-DPAT is independent of changes in dopamine release

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Dose-dependent effects of the D3-preferring agonist 7-OH-DPAT on motor behaviors and place conditioning

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Behavioural effects in the rat of the putative dopamine D3 receptor agonist 7-OH-DPAT: comparison with quinpirole and apomorphine.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Dopamine D3 agonists disrupt social behavior in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

7-OH-DPAT injected into the accumbens reduces locomotion and sucrose ingestion: D3 autoreceptor-mediated effects?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Effects on locomotor activity after local application of D3 preferring compounds in discrete areas of the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Motor actions of 7-OH-DPAT in normal and reserpine-treated mice suggest involvement of both dopamine D2 and D3 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Dopamine D3 receptor agonists produce similar decreases in body temperature and locomotor activity in D3 knock-out and wild-type mice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Dopamine D2 receptor knock-out mice are insensitive to the hypolocomotor and hypothermic effects of dopamine D2/D3 receptor agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Homozygosity at the dopamine D3 receptor gene is associated with opiate dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

The role of mesoaccumbens--pallidal circuitry in novelty-induced behavioral activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Heterogeneity of behavioural profile between three new putative selective D3 dopamine receptor antagonists using an ethologically based approach

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Differential effects of dopamine D2 and D3 receptor antagonists in regard to dopamine release, in vivo receptor displacement and behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

The dopamine D3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

(+)-AJ 76 and (+)-UH 232: central stimulants acting as preferential dopamine autoreceptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Pharmacological characterization of PD 152255, a novel dimeric benzimidazole dopamine D3 antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

In vivo occupancy of D2 dopamine receptors by nafadotride

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Antagonism of cocaine's pharmacological effects by the stimulant dopaminergic antagonists, (+)-AJ76 and (+)-UH232

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

NGB 2904 and NGB 2849: two highly selective dopamine D3 receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

The dopamine D3 receptor and schizophrenia: pharmacological, anatomical and genetic approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Decreased binding of dopamine D3 receptors in limbic subregions after neonatal bilateral lesion of rat hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Electrophysiological evidence for A10 dopamine autoreceptor subsensitivity following chronic D-amphetamine treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Effects of Daily Cocaine and Morphine Treatment on Somatodendritic and Terminal Field Dopamine Release

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Chronic cocaine treatment impairs the regulation of synaptosomal 3H-DA release by D2 autoreceptors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Changes in sensitivity of dopamine autoreceptors in rat striatum after subchronic treatment with methamphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Acute amphetamine-induced subsensitivity of A10 dopamine autoreceptors in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Effects of repeated administration of the preferential dopamine autoreceptor antagonist, (+)-AJ76, on locomotor activity and brain DA metabolism in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Differential regulation, by MK-801, of dopamine receptor gene expression in rat nigrostriatal and mesocorticolimbic systems.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Lack of autoreceptor-mediated inhibitory control of dopamine release in striatal synaptosomes of D2 receptor-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Biological consequences of drug administration: implications for acute and chronic tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Morphine tolerance as habituation.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Homeostatic theory of drug tolerance: a general model of physiological adaptation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Learning alcohol tolerance: the contribution of response expectancies

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Pavlovian influences over food and drug intake

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

The eating paradox: how we tolerate food

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Regulation of anterior pituitary D2 dopamine receptors by magnesium and sodium ions.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Dependence of dopamine receptor conversion from agonist high- to low-affinity state on temperature and sodium ions

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Properties of D2 dopamine receptor autoradiography: high percentage of high-affinity agonist sites and increased nucleotide sensitivity in tissue sections.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Anatomical and affinity state comparisons between dopamine D1 and D2 receptors in the rat central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

The functional state of the dopamine receptor in the anterior pituitary is in the high affinity form.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Synaptic Concentration of Dopamine in the Mouse Striatum in Relationship to the Kinetic Properties of the Dopamine Receptors and Uptake Mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Extracellular Concentration and In Vivo Recovery of Dopamine in the Nucleus Accumbens Using Microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Regulation of transient dopamine concentration gradients in the microenvironment surrounding nerve terminals in the rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Functional and anatomical evidence for different dopamine dynamics in the core and shell of the nucleus accumbens in slices of rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Effects of intermittent and continuous cocaine administration on dopamine release and uptake regulation in the striatum: in vitro voltammetric assessment.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

In vivo measurement of dopamine and its metabolites by intracerebral dialysis: changes after d-amphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

The role of dopamine in the mouse frontal cortex: a new hypothesis of behavioral sensitization to amphetamine and cocaine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

The role of dopamine and GABA in the frontal cortex of mice in modulating a motor-stimulant effect of amphetamine and cocaine.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Interactions between dopamine and excitatory amino acids in behavioral sensitization to psychostimulants

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

D1 receptors modulate glutamate transmission in the ventral tegmental area

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Dopaminergic modulation of glutamate release in striatum as measured by microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Dopamine regulation of extracellular glutamate in the nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Presynaptic dopamine D2-like receptors inhibit excitatory transmission onto rat ventral tegmental dopaminergic neurones

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Neuroprotective effects of the dopamine D2/D3 agonist pramipexole against postischemic or methamphetamine-induced degeneration of nigrostriatal neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Chronic D-amphetamine in nucleus accumbens: lack of tolerance or reverse tolerance of locomotor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine: lack of conditioned effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Sensitization and individual differences to IP amphetamine, cocaine, or caffeine following repeated intracranial amphetamine infusions

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Amphetamine: effects on catecholamine systems and behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Tolerance to ethanol's effects on operant performance in rats: role of number and pattern of intoxicated practice opportunities

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Increased locomotor response to novelty and propensity to intravenous amphetamine self-administration in adult offspring of stressed mothers

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Prenatal stress in rats facilitates amphetamine-induced sensitization and induces long-lasting changes in dopamine receptors in the nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Cocaine-induced behavioral sensitization: effects of haloperidol and SCH 23390 treatments.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Interactions between chronic haloperidol treatment and cocaine in rats: an animal model of intermittent cocaine use in neuroleptic treated populations.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Long-term influence of d-amphetamine on mesolimbic brain-stimulation reward: comparison to chronic haloperidol and naloxone effects

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Ethanol reduces tolerance, sensitization, and up-regulation of D2-receptors after subchronic haloperidol.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Selective antagonism of dopamine D1 and D2 receptors does not block the development of behavioral sensitization to cocaine.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Clozapine and haloperidol block the induction of behavioral sensitization to amphetamine and associated genomic responses in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Effects of dopamine antagonism on methamphetamine sensitization: evaluation by ambulatory activity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

The role of the frontal cortex in the mouse in behavioral sensitization to amphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Early post-treatment with haloperidol retards induction of methamphetamine sensitization in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Effects of sulpiride and nemonapride, benzamide derivatives having distinct potencies of antagonistic action on dopamine D2 receptors, on sensitization to methamphetamine in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Effects of selective D-1 and D-2 dopamine antagonists on development of methamphetamine-induced behavioral sensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

The dopamine D3 receptor antagonist nafadotride inhibits development of locomotor sensitization to amphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Quantification of dopamine D3 receptor mRNA level associated with the development of amphetamine-induced behavioral sensitization in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Repeated intravenous cocaine administration: locomotor activity and dopamine D2/D3 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

D3 dopamine and kappa opioid receptor alterations in human brain of cocaine-overdose victims

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Up-regulation of D3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Enhancement of dopamine actions on rat nucleus accumbens neurones in vitro after methamphetamine pre-treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Chronic cocaine treatment decreases levels of the G protein subunits Gi alpha and Go alpha in discrete regions of rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Long-term amphetamine treatment attenuates or reverses the depression of neuronal activity produced by dopamine agonists in the ventral tegmental area.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

A10 somatodendritic dopamine autoreceptor sensitivity following withdrawal from repeated cocaine treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Regulation of transmembrane signaling by receptor phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Internalization of D1 dopamine receptor in striatal neurons in vivo as evidence of activation by dopamine agonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Resistance of the dopamine D2L receptor to desensitization accompanies the up-regulation of receptors on to the surface of Sf9 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Regulation of D2 and D3 receptors in transfected cells by agonists and antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Human dopamine D3 and D2L receptors couple to inward rectifier potassium channels in mammalian cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Ethanol tolerance in the rat is learned

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Heroin "overdose" death: contribution of drug-associated environmental cues

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Cocaine conditioning and cocaine sensitization: what is the relationship?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Characterization of the associative nature of sensitization to amphetamine-induced circling behavior and of the environment dependent placebo-like response.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Antipsychotic drug doses and neuroleptic/dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Relationship between dopaminergic and serotonergic neuronal activity in the frontal cortex and the action of typical and atypical antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Long-term blockade of the expression of cocaine sensitization by ondansetron, a 5-HT(3) receptor antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Clinical features of cocaine-induced paranoia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Enhanced response to repeated d-amphetamine challenge: evidence for behavioral sensitization in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Progressive behavioral response to repeated d-amphetamine challenge: further evidence for sensitization in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Lack of enhanced response to repeated d-amphetamine challenge in first-episode psychosis: implications for a sensitization model of psychosis in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Atypical antipsychotic-like effects of the dopamine D3 receptor agonist, (+)-PD 128,907

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Effects of the D3 and autoreceptor-preferring dopamine antagonist (+)-UH232 in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Antipsychotic properties of the partial dopamine agonist (-)-3-(3-hydroxyphenyl)-N-n-propylpiperidine(preclamol) in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Pramipexole as adjunct to haloperidol in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Association between schizophrenia and homozygosity at the dopamine D3 receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

A meta-analysis and transmission disequilibrium study of association between the dopamine D3 receptor gene and schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Dopamine receptor transcript expression in striatum and prefrontal and occipital cortex. Focal abnormalities in orbitofrontal cortex in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Neural systems for behavioral activation and reward

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

A common mechanism mediates long-term changes in synaptic transmission after chronic cocaine and morphine.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2801%2900023-9

7 January 2021

10.1016/S0149-7634(01)00023-9

Identifiers

DOI

1 reference

1 August 2017

1 reference